Oncology Molecular Diagnostics Global Market Report 2022 Including: 1) By Product: Instruments; Reagents; Other Products 2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INN

Oncology Molecular Diagnostics Global Market Report 2022

Oncology Molecular Diagnostics Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology molecular diagnostics market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the oncology molecular diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Molecular Diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider oncology molecular diagnostics market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology molecular diagnostics market section of the report gives context. It compares the oncology molecular diagnostics market with other segments of the oncology molecular diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology molecular diagnostics indicators comparison.
Scope

Markets Covered: 1) By Product: Instruments; Reagents; Other Products

2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Other Technologies

3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Other End Users

Companies Mentioned: Abbott Diagnostics; Becton Dickinson; Cepheid; Danaher Corporation; Beckman Coulter

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Oncology Molecular Diagnostics Market Characteristics
3. Oncology Molecular Diagnostics Market Trends And Strategies
4. Impact Of COVID-19 On Oncology Molecular Diagnostics
5. Oncology Molecular Diagnostics Market Size And Growth
5.1. Global Oncology Molecular Diagnostics Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Oncology Molecular Diagnostics Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Oncology Molecular Diagnostics Market Segmentation
6.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Instruments
Reagents
Other Products
6.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Polymerase Chain Reaction (PCR)
In-situ Hybridization (ISH)
Isothermic Nucleic Acid Amplification Technology (INNAT)
Chips & Microarrays
Sequencing
Mass Spectroscopy
Transcription Mediated Amplification (TMA)
Other Technologies
6.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospitals
Diagnostic Centers
Academic & Research Institutes
Other End Users
7. Oncology Molecular Diagnostics Market Regional And Country Analysis
7.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Oncology Molecular Diagnostics Market
8.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Oncology Molecular Diagnostics Market
9.1. China Oncology Molecular Diagnostics Market Overview
9.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Oncology Molecular Diagnostics Market
10.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Oncology Molecular Diagnostics Market
11.1. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Oncology Molecular Diagnostics Market
12.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Oncology Molecular Diagnostics Market
13.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Oncology Molecular Diagnostics Market
14.1. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Oncology Molecular Diagnostics Market
15.1. Western Europe Oncology Molecular Diagnostics Market Overview
15.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Oncology Molecular Diagnostics Market
16.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Oncology Molecular Diagnostics Market
17.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Oncology Molecular Diagnostics Market
18.4. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Oncology Molecular Diagnostics Market
19.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
19.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Oncology Molecular Diagnostics Market
20.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Oncology Molecular Diagnostics Market
21.1. North America Oncology Molecular Diagnostics Market Overview
21.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Oncology Molecular Diagnostics Market
22.1. USA Oncology Molecular Diagnostics Market Overview
22.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Oncology Molecular Diagnostics Market
23.1. South America Oncology Molecular Diagnostics Market Overview
23.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Oncology Molecular Diagnostics Market
24.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Oncology Molecular Diagnostics Market
25.1. Middle East Oncology Molecular Diagnostics Market Overview
25.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Oncology Molecular Diagnostics Market
26.1. Africa Oncology Molecular Diagnostics Market Overview
26.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles
27.1. Oncology Molecular Diagnostics Market Competitive Landscape
27.2. Oncology Molecular Diagnostics Market Company Profiles
27.2.1. Abbott Diagnostics
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Becton Dickinson
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Cepheid
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Danaher Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Beckman Coulter
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market
29. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings